Overview
Shuichi Mizuta practices in Kanazawa, Japan. Mr. Mizuta is rated as an Experienced expert by MediFind in the treatment of ABO Incompatibility. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Lymphoid Hyperplasia, B-Cell Lymphoma, and Bone Marrow Transplant.
His clinical research consists of co-authoring 59 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of ABO Incompatibility.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- B-Cell LymphomaMr. Mizuta isAdvanced. Learn about B-Cell Lymphoma.
- Bone Marrow TransplantMr. Mizuta isAdvanced. Learn about Bone Marrow Transplant.
- LeukemiaMr. Mizuta isAdvanced. Learn about Leukemia.
- Lymphoid HyperplasiaMr. Mizuta isAdvanced. Learn about Lymphoid Hyperplasia.
- Experienced
- ABO IncompatibilityMr. Mizuta isExperienced. Learn about ABO Incompatibility.
- Acute Myeloid Leukemia (AML)Mr. Mizuta isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Angioimmunoblastic T-cell LymphomaMr. Mizuta isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- Castleman DiseaseMr. Mizuta isExperienced. Learn about Castleman Disease.
- Chronic Myelogenous Leukemia (CML)Mr. Mizuta isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Diffuse Large B-Cell Lymphoma (DLBCL)Mr. Mizuta isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).